Comparative Benchmarking
In the context of the broader market, OKYO competes directly with industry leaders such as MREO and IMA. With a market capitalization of $76.73M, it holds a significant position in the sector. When comparing efficiency, OKYO's gross margin of N/A stands against MREO's 73.40% and IMA's 100.00%. Such benchmarking helps identify whether OKYO Pharma Ltd is trading at a premium or discount relative to its financial performance.
